Parexel to support South Korean pharma sector's globalisation effort
This article was originally published in Scrip
Executive Summary
Parexel has been chosen by the Korean Drug Development Fund (KDDF) as the first contract research organisation to help South Korean companies develop and commercialise healthcare products for the global market.